federal_register: 2012-24748
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2012-24748 | Guidance for Industry on Acute Bacterial Sinusitis: Developing Drugs for Treatment; Availability | Notice | The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled "Acute Bacterial Sinusitis: Developing Drugs for Treatment." This guidance addresses FDA's current thinking regarding the overall development program and clinical trial designs for drugs to support an indication for the treatment of acute bacterial sinusitis (ABS). This guidance finalizes the revised draft guidance of the same name issued on October 30, 2007. | 2012-10-09 | 2012 | 10 | https://www.federalregister.gov/documents/2012/10/09/2012-24748/guidance-for-industry-on-acute-bacterial-sinusitis-developing-drugs-for-treatment-availability | https://www.govinfo.gov/content/pkg/FR-2012-10-09/pdf/2012-24748.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled "Acute Bacterial Sinusitis: Developing Drugs for Treatment." This guidance addresses FDA's current thinking regarding the overall development... |